Stimulating endogenous cardiac repair

Frontiers in Cell and Developmental Biology

Volumn 3, Issue SEP, 2015, Pages

  Finan, Amanda ^a   Richard, Sylvain ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Beta blockers; Cardiac progenitor cells; Cell therapy; Gene therapy; Regeneration; Statins; Stem cells

Indexed keywords

EID: 84964316944     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2015.00057     Document Type: Review

References (140)

1. Anderson, M. E., Goldhaber, J., Houser, S. R., Puceat, M., and Sussman, M. A. (2014). Embryonic stem cell-derived cardiac myocytes are not ready for human trials. Circ. Res. 115, 335-338. doi: 10.1161/CIRCRESAHA.114.304616
2. Angeli, F., Reboldi, G., Mazzotta, G., Garofoli, M., Cerasa, M. F., and Verdecchia, P. (2012). Statins in acute coronary syndrome: very early initiation and benefits. Ther. Adv. Cardiovasc. Dis. 6, 163-174. doi: 10.1177/1753944712452463
3. Askari, A. T., Unzek, S., Popovic, Z. B., Goldman, C. K., Forudi, F., Kiedrowski, M., et al. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697-703. doi: 10.1016/S0140-6736(03)14232-8
4. Avolio, E., Meloni, M., Spencer, H. L., Riu, F., Katare, R., Mangialardi, G., et al. (2015). Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. Circ. Res. 115:306146. doi: 10.1161/CIRCRESAHA.115.306146
5. Bär, C., Bernardes de Jesus, B., Serrano, R., Tejera, A., Ayuso, E., Jimenez, V., et al. (2014). Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction. Nat. Commun. 5:5863 doi: 10.1038/ncomms6863
6. Barile, L., Cerisoli, F., Frati, G., Gaetani, R., Chimenti, I., Forte, E., et al. (2011). Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart. J. Cell. Mol. Med. 15, 63-71. doi: 10.1111/j.1582-4934.2009.00968.x
7. Baumer, Y., Leder, C., Ziegler, M., Schönberger, T., Ochmann, C., Perk, A., et al. (2012). The recombinant bifunctional protein aCD133-GPVI promotes repair of the infarcted myocardium in mice. J. Thromb. Haemost. 10, 1152-1164. doi: 10.1111/j.1538-7836.2012.04710.x
8. Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776. doi: 10.1016/S0092-8674(03)00687-1
9. Beltrami, A. P., Urbanek, K., Kajstura, J., Yan, S.-M., Finato, N., Bussani, R., et al. (2001). Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344, 1750-1757. doi: 10.1056/NEJM200106073442303
10. Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., et al. (2009). Evidence for cardiomyocyte renewal in humans. Science 324, 98-102. doi: 10.1126/science.1164680
11. Bergmann, O., and Jovinge, S. (2014). Cardiac regeneration in vivo: mending the heart from within? Stem Cell Res. 13(3 Pt B), 523-531. doi: 10.1016/j.scr.2014.07.002
12. Boer, H. C., de Hovens, M. M., Oeveren-Rietdijk, A. M., van Snoep, J. D., Koning, E. J. P., de Tamsma, J. T., et al. (2011). Human CD34+/KDR+ cells are generated from circulating CD34+ cells after immobilization on activated platelets. Arterioscler. Thromb. Vasc. Biol. 31, 408-415. doi: 10.1161/ATVBAHA.110.216879
13. Bolli, R., Chugh, A. R., D'Amario, D., Loughran, J. H., Stoddard, M. F., Ikram, S., et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378, 1847-1857. doi: 10.1016/S0140-6736(11)61590-0
14. Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., et al. (2009). MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710-1713. doi: 10.1126/science.1174381
15. Bristow, M. R., Ginsburg, R., Umans, V., Fowler, M., Minobe, W., Rasmussen, R., et al. (1986). Beta 1-and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ. Res. 59, 297-309. doi: 10.1161/01.RES.59.3.297
16. Burger, L., and Hirschler, B. (2014). First gene therapy drug sets million-euro price record. Reuters. Available online at: http://www.reuters.com/article/2014/11/26/us-health-genetherapy-price-idUSKCN0JA1TP20141126
17. Cai, A., Qiu, R., Li, L., Zheng, D., Dong, Y., Yu, D., et al. (2013). Atorvastatin Treatment of Rats with Ischemia-Reperfusion Injury Improves Adipose-Derived Mesenchymal Stem Cell Migration and Survival via the SDF-1a/CXCR-4 Axis. PLoS ONE 8:e79100. doi: 10.1371/journal.pone.0079100
18. Chernyavskaya, Y., Ebert, A. M., Milligan, E., and Garrity, D. M. (2012). Voltage-gated calcium channel CACNB2 (β2.1) protein is required in the heart for control of cell proliferation and heart tube integrity. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 241, 648-662. doi: 10.1002/dvdy.23746
19. Chillar, A., So, S.-P., Ruan, C.-H., Shelat, H., Geng, Y.-J., and Ruan, K.-H. (2011). A profile of NSAID-targeted arachidonic acid metabolisms in human embryonic stem cells (hESCs): implication of the negative effects of NSAIDs on heart tissue regeneration. Int. J. Cardiol. 150, 253-259. doi: 10.1016/j.ijcard.2010.04.015
20. Chong, J. J. H., Yang, X., Don, C. W., Minami, E., Liu, Y.-W., Weyers, J. J., et al. (2014). Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273-277. doi: 10.1038/nature13233
21. Chung, E. S., Miller, L., Patel, A. N., Anderson, R. D., Mendelsohn, F. O., Traverse, J., et al. (2015). Changes in ventricular remodelling and clincal status during the year following a single adminstration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial. Eur. Heart J. 36, 2228-2238. doi: 10.1093/eurheartj/ehv254
22. Cohen, K. S., Cheng, S., Larson, M. G., Cupples, L. A., McCabe, E. L., Wang, Y. A., et al. (2013). Circulating CD34+ progenitor cell frequency is associated with clinical and genetic factors. Blood 121, e50-e56. doi: 10.1182/blood-2012-05-424846
23. D'Amario, D., Cabral-Da-Silva, M. C., Zheng, H., Fiorini, C., Goichberg, P., Steadman, E., et al. (2011). Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ. Res. 108, 1467-1481. doi: 10.1161/CIRCRESAHA.111.240648
24. de Almeida, P. E., Meyer, E. H., Kooreman, N. G., Diecke, S., Dey, D., Sanchez-Freire, V., et al. (2014). Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat. Commun. 5:3903. doi: 10.1038/ncomms4903
25. Deb, A., Wang, S., Skelding, K. A., Miller, D., Simper, D., and Caplice, N. M. (2003). Bone marrow-derived cardiomyocytes are present in adult human heart a study of gender-mismatched bone marrow transplantation patients. Circulation 107, 1247-1249. doi: 10.1161/01.CIR.0000061910.39145.F0
26. Demion, M., Thireau, J., Gueffier, M., Finan, A., Khoueiry, Z., Cassan, C., et al. (2014). Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations. PLoS ONE 9:e115256. doi: 10.1371/journal.pone.0115256
27. Deng, L., Hu, S., Baydoun, A. R., Chen, J., Chen, X., and Cong, X. (2009). Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt/β-catenin pathway. Cell Prolif. 42, 721-730. doi: 10.1111/j.1365-2184.2009.00639.x
28. Dong, F., Harvey, J., Finan, A., Weber, K., Agarwal, U., and Penn, M. S. (2012). Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation 126, 314-324. doi: 10.1161/CIRCULATIONAHA.111.082453
29. Durik, M., Sevá Pessôa, B., and Roks, A. J. M. (2012). The renin-angiotensin system, bone marrow and progenitor cells. Clin. Sci. Lond. Engl. 123, 205-223. doi: 10.1042/cs20110660
30. Ellison, G. M., Torella, D., Karakikes, I., Purushothaman, S., Curcio, A., Gasparri, C., et al. (2007). Acute β-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J. Biol. Chem. 282, 11397-11409. doi: 10.1074/jbc.M607391200
31. Ellison, G. M., Vicinanza, C., Smith, A. J., Aquila, I., Leone, A., Waring, C. D., et al. (2013). Adult c-kitpos cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154, 827-842. doi: 10.1016/j.cell.2013.07.039
32. Erbs, S., Beck, E. B., Linke, A., Adams, V., Gielen, S., Kränkel, N., et al. (2011). High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling-Results from a randomized, double-blind, and placebo-controlled study. Int. J. Cardiol. 146, 56-63. doi: 10.1016/j.ijcard.2010.02.019
33. Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., et al. (2012). Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381. doi: 10.1038/nature11739
34. Favaloro, L., Diez, M., Mendiz, O., Janavel, G. V., Valdivieso, L., Ratto, R., et al. (2013). High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial. Catheter. Cardiovasc. Interv. 82, 899-906. doi: 10.1002/ccd.24555
35. Fazel, S. (2006). Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116, 1865-1877. doi: 10.1172/JCI27019
36. Ferreira-Martins, J., Rondon-Clavo, C., Tugal, D., Korn, J. A., Rizzi, R., Padin-Iruegas, M. E., et al. (2009). Spontaneous calcium oscillations regulate human cardiac progenitor cell growth. Circ. Res. 105, 764-774. doi: 10.1161/CIRCRESAHA.109.206698
37. Finan, A., Kiedrowski, M., Turturice, B. A., Sopko, N. A., and Penn, M. S. (2012). Cardiac pressure overload initiates a systemic stem cell response. Cytotherapy 14, 983-993. doi: 10.3109/14653249.2012.684380
38. Finan, A., Sopko, N., Dong, F., Turturice, B., Kiedrowski, M., and Penn, M. S. (2013). Bone marrow SSEA1+ cells support the myocardium in cardiac pressure overload. PLoS ONE 8:e68528. doi: 10.1371/journal.pone.0068528
39. Fischer, K. M., Cottage, C. T., Wu, W., Din, S., Gude, N. A., Avitabile, D., et al. (2009). Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing pim-1 kinase. Circulation 120, 2077-2087. doi: 10.1161/CIRCULATIONAHA.109.884403
40. Fransioli, J., Bailey, B., Gude, N. A., Cottage, C. T., Muraski, J. A., Emmanuel, G., et al. (2008). Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells Dayt. Ohio 26, 1315-1324. doi: 10.1634/stemcells.2007-0751
41. Gambini, E., Pesce, M., Persico, L., Bassetti, B., Gambini, A., Alamanni, F., et al. (2012). Patient profile modulates cardiac c-kit(+) progenitor cell availability and amplification potential. Transl. Res. J. Lab. Clin. Med. 160, 363-373. doi: 10.1016/j.trsl.2012.05.009
42. Gautam, M., Fujita, D., Kimura, K., Ichikawa, H., Izawa, A., Hirose, M., et al. (2015). Transplantation of adipose tissue-derived stem cells improves cardiac contractile function and electrical stability in a rat myocardial infarction model. J. Mol. Cell. Cardiol. 81, 139-149. doi: 10.1016/j.yjmcc.2015.02.012
43. Genead, R., Danielsson, C., Andersson, A. B., Corbascio, M., Franco-Cereceda, A., Sylvén, C., et al. (2010). Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood. Stem Cells Dev. 19, 1601-1615. doi: 10.1089/scd.2009.0483
44. Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., et al. (2014). Heart disease and stroke statistics-2014 update a report from the American heart association. Circulation 129, e28-e292. doi: 10.1161/01.cir.0000442015.53336.12
45. Golpanian, S., El-Khorazaty, J., Mendizabal, A., DiFede, D. L., Suncion, V. Y., Karantalis, V., et al. (2015). Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients. J. Am. Coll. Cardiol. 65, 125-132. doi: 10.1016/j.jacc.2014.10.040
46. Gong, Y., Zhao, Y., Li, Y., Fan, Y., and Hoover-Plow, J. (2014). Plasminogen regulates cardiac repair after myocardial infarction through its noncanonical function in stem cell homing to the infarcted heart. J. Am. Coll. Cardiol. 63, 2862-2872. doi: 10.1016/j.jacc.2013.11.070
47. Goumans, M.-J., Maring, J. A., and Smits, A. M. (2014). A straightforward guide to the basic science behind cardiovascular cell-based therapies. Heart 100, 1153-1157. doi: 10.1136/heartjnl-2014-305646
48. Gyöngyösi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., Bartunek, J., et al. (2015). Meta-analysis of cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ. Res. 116, 1346-1360. doi: 10.1161/CIRCRESAHA.116.304346
49. Hariharan, N., and Sussman, M. A. (2015). Cardiac aging-Getting to the stem of the problem. J. Mol. Cell. Cardiol. 83, 32-36. doi: 10.1016/j.yjmcc.2015.04.008
50. Hodgkinson, C. P., Kang, M. H., Dal-Pra, S., Mirotsou, M., and Dzau, V. J. (2015). MicroRNAs and cardiac regeneration. Circ. Res. 116, 1700-1711. doi: 10.1161/CIRCRESAHA.116.304377
51. Hsiao, L.-C., Perbellini, F., Gomes, R. S., Tan, J. J., Vieira, S., Faggian, G., et al. (2014). Murine cardiosphere-derived cells are impaired by age but not by cardiac dystrophic dysfunction. Stem Cells Dev. 23, 1027-1036. doi: 10.1089/scd.2013.0388
52. Hsieh, P. C. H., Segers, V. F. M., Davis, M. E., MacGillivray, C., Gannon, J., Molkentin, J. D., et al. (2007). Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13, 970-974. doi: 10.1038/nm1618
53. Huang, B., Qian, J., Ma, J., Huang, Z., Shen, Y., Chen, X., et al. (2014). Myocardial transfection of hypoxia-inducible factor-1a and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction. Stem Cell Res. Ther. 5, 22. doi: 10.1186/scrt410
54. Huang, M., Nguyen, P., Jia, F., Hu, S., Gong, Y., de Almeida, P. E., et al. (2011). Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation 124, S46-S54. doi: 10.1161/CIRCULATIONAHA.110.014019
55. Inagawa, K., Miyamoto, K., Yamakawa, H., Muraoka, N., Sadahiro, T., Umei, T., et al. (2012). Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ. Res. 111, 1147-1156. doi: 10.1161/CIRCRESAHA.112.271148
56. Ishii, M., Shibata, R., Shimizu, Y., Yamamoto, T., Kondo, K., Inoue, Y., et al. (2014). Multilayered adipose-derived regenerative cell sheets created by a novel magnetite tissue engineering method for myocardial infarction. Int. J. Cardiol. 175, 545-553. doi: 10.1016/j.ijcard.2014.06.034
57. Ishikawa, K., Fish, K., Aguero, J., Yaniz-Galende, E., Jeong, D., Kho, C., et al. (2015). Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine. Circ. Heart Fail. 8, 167-174. doi: 10.1161/CIRCHEARTFAILURE.114.001711
58. Ito, M., Adachi, T., Pimentel, D. R., Ido, Y., and Colucci, W. S. (2004). Statins inhibit β-Adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism. Circulation 110, 412-418. doi: 10.1161/01.CIR.0000136088.18960.E6
59. Iwasaki, H., Kawamoto, A., Tjwa, M., Horii, M., Hayashi, S., Oyamada, A., et al. (2011). PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors. PLoS ONE 6:e24872. doi: 10.1371/journal.pone.0024872
60. Jayawardena, T. M., Finch, E. A., Zhang, L., Zhang, H., Hodgkinson, C. P., Pratt, R. E., et al. (2015). MicroRNA induced cardiac reprogramming in vivo evidence for mature cardiac myocytes and improved cardiac function. Circ. Res. 116, 418-424. doi: 10.1161/CIRCRESAHA.116.304510
61. Jesty, S. A., Steffey, M. A., Lee, F. K., Breitbach, M., Hesse, M., Reining, S., et al. (2012). c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc. Natl. Acad. Sci. U.S.A. 109, 13380-13385. doi: 10.1073/pnas.1208114109
62. Jopling, C., Sleep, E., Raya, M., Martí, M., Raya, A., and Belmonte, J. C. I. (2010). Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464, 606-609. doi: 10.1038/nature08899
63. Jung, C., Florvaag, A., Oberle, V., Fritzenwanger, M., Kretschmar, D., Kuethe, F., et al. (2012). Positive effect of eplerenone treatment on endothelial progenitor cells in patients with chronic heart failure. J. Renin Angiotensin Aldosterone Syst. 13, 401-406. doi: 10.1177/1470320312447650
64. Kajstura, J., Cigola, E., Malhotra, A., Li, P., Cheng, W., Meggs, L. G., et al. (1997). Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Mol. Cell. Cardiol. 29, 859-870. doi: 10.1006/jmcc.1996.0333
65. Kajstura, J., Leri, A., Finato, N., Di Loreto, C., Beltrami, C. A., and Anversa, P. (1998). Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. U.S.A. 95, 8801-8805. doi: 10.1073/pnas.95.15.8801
66. Kajstura, J., Urbanek, K., Perl, S., Hosoda, T., Zheng, H., Ogórek, B., et al. (2010). Cardiomyogenesis in the adult human heart. Circ. Res. 107, 305-315. doi: 10.1161/CIRCRESAHA.110.223024
67. Kanashiro-Takeuchi, R. M., Schulman, I. H., and Hare, J. M. (2011). Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration. J. Mol. Cell. Cardiol. 51, 619-625. doi: 10.1016/j.yjmcc.2011.05.015
68. Katz, M. G., Fargnoli, A. S., Williams, R. D., Steuerwald, N. M., Isidro, A., Ivanina, A. V., et al. (2014). Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca2+ adenosine triphosphatase delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 148, 1065-1073.e2. doi: 10.1016/j.jtcvs.2014.05.070
69. Khan, M., Mohsin, S., Avitabile, D., Siddiqi, S., Nguyen, J., Wallach, K., et al. (2013). β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation. Circ. Res. 112, 476-486. doi: 10.1161/CIRCRESAHA.112.280735
70. Khan, M., Nickoloff, E., Abramova, T., Johnson, J., Verma, S. K., Krishnamurthy, P., et al. (2015). Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ. Res. 115:305990. doi: 10.1161/CIRCRESAHA.117.305990
71. Kikuchi, K., Holdway, J. E., Werdich, A. A., Anderson, R. M., Fang, Y., Egnaczyk, G. F., et al. (2010). Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes. Nature 464, 601-605. doi: 10.1038/nature08804
72. Kim, S.-W., Houge, M., Brown, M., Davis, M. E., and Yoon, Y. (2014). Cultured human bone marrow-derived CD31+ cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects. J. Am. Coll. Cardiol. 64, 1681-1694. doi: 10.1016/j.jacc.2014.06.1204
73. Kucia, M., Reca, R., Campbell, F. R., Zuba-Surma, E., Majka, M., Ratajczak, J., et al. (2006). A population of very small embryonic-like (VSEL) CXCR4+SSEA-1+Oct-4+ stem cells identified in adult bone marrow. Leukemia 20, 857-869. doi: 10.1038/sj.leu.2404171
74. Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015-1024. doi: 10.1038/nbt1327
75. Laflamme, M. A., and Murry, C. E. (2011). Heart regeneration. Nature 473, 326-335. doi: 10.1038/nature10147
76. Lalit, P. A., Hei, D. J., Raval, A. N., and Kamp, T. J. (2014). Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ. Res. 114, 1328-1345. doi: 10.1161/CIRCRESAHA.114.300556
77. Lazar, L. D., Pletcher, M. J., Coxson, P. G., Bibbins-Domingo, K., and Goldman, L. (2011). Cost-effectiveness of statin therapy for primary prevention in a low-cost statin Era. Circulation 124, 146-153. doi: 10.1161/CIRCULATIONAHA.110.986349
78. Lee, P. S. S., and Poh, K. K. (2014). Endothelial progenitor cells in cardiovascular diseases. World J. Stem Cells 6, 355-366. doi: 10.4252/wjsc.v6.i3.355
79. Leja, M. J., Shah, D. J., and Reardon, M. J. (2011). Primary cardiac tumors. Tex. Heart Inst. J. 38, 261-262
80. Li, L., Zeng, H., and Chen, J.-X. (2012). Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 303, H605-H618. doi: 10.1152/ajpheart.00366.2012
81. Lin, Z., von Gise, A., Zhou, P., Gu, F., Ma, Q., Jiang, J., et al. (2014). Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model. Circ. Res. 115, 354-363. doi: 10.1161/CIRCRESAHA.115.303632
82. Liu, C., Fan, Y., Zhou, L., Zhu, H.-Y., Song, Y.-C., Hu, L., et al. (2015). Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction. Int. J. Cardiol. 188, 22-32. doi: 10.1016/j.ijcard.2015.03.425
83. Loffredo, F. S., Steinhauser, M. L., Gannon, J., and Lee, R. T. (2011). Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8, 389-398. doi: 10.1016/j.stem.2011.02.002
84. Mahmoud, A. I., Kocabas, F., Muralidhar, S. A., Kimura, W., Koura, A. S., Thet, S., et al. (2013). Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 497, 249-253. doi: 10.1038/nature12054
85. Malecki, M., Sabo, C., Putzer, E., Stampe, C., Foorohar, A., Quach, C., et al. (2013). Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: novel strategy for cardiac regeneration. Mol. Cell. Ther. 1:4. doi: 10.1186/2052-8426-1-4
86. Malliaras, K., Ibrahim, A., Tseliou, E., Liu, W., Sun, B., Middleton, R. C., et al. (2014a). Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction. EMBO Mol. Med. 6, 760-777. doi: 10.1002/emmm.201303626
87. Malliaras, K., Makkar, R. R., Smith, R. R., Cheng, K., Wu, E., Bonow, R. O., et al. (2014b). Intracoronary cardiosphere-derived cells after myocardial infarction. J. Am. Coll. Cardiol. 63, 110-122. doi: 10.1016/j.jacc.2013.08.724
88. Mathiasen, A. B., Qayyum, A. A., Jørgensen, E., Helqvist, S., Fischer-Nielsen, A., Kofoed, K. F., et al. (2015). Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur. Heart J. 36, 1744-1753. doi: 10.1093/ eurheartj/ehv136
89. Mentz, R. J., Bakris, G. L., Waeber, B., McMurray, J. J. V., Gheorghiade, M., Ruilope, L. M., et al. (2013). The past, present and future of renin-angiotensin aldosterone system inhibition. Int. J. Cardiol. 167, 1677-1687. doi: 10.1016/j.ijcard.2012.10.007
90. Mirantes, C., Passegué, E., and Pietras, E. M. (2014). Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp. Cell Res. 329, 248-254. doi: 10.1016/j.yexcr.2014.08.017
91. Mollova, M., Bersell, K., Walsh, S., Savla, J., Das, L. T., Park, S.-Y., et al. (2013). Cardiomyocyte proliferation contributes to heart growth in young humans. Proc. Natl. Acad. Sci. U.S.A. 110, 1446-1451. doi: 10.1073/pnas.1214608110
92. Mouquet, F., Pfister, O., Jain, M., Oikonomopoulos, A., Ngoy, S., Summer, R., et al. (2005). Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ. Res. 97, 1090-1092. doi: 10.1161/01.RES.0000194330.66545.f5
93. Musumeci, M., Maccari, S., Sestili, P., Signore, M., Molinari, P., Ambrosio, C., et al. (2011). Propranolol enhances cell cycle-related gene expression in pressure overloaded hearts. Br. J. Pharmacol. 164, 1917-1928. doi: 10.1111/j.1476-5381.2011.01504.x
94. Nagai, T., and Komuro, I. (2012). Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function. Am. J. Physiol. Heart Circ. Physiol. 303, H501-H512. doi: 10.1152/ajpheart.00130.2012
95. Naqvi, N., Li, M., Calvert, J. W., Tejada, T., Lambert, J. P., Wu, J., et al. (2014). A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 157, 795-807. doi: 10.1016/j.cell.2014.03.035
96. Ong, S.-G., Lee, W. H., Huang, M., Dey, D., Kodo, K., Sanchez-Freire, V., et al. (2014). Cross talk of combined gene and cell therapy in ischemic heart disease role of exosomal MicroRNA transfer. Circulation 130, S60-S69. doi: 10.1161/CIRCULATIONAHA.113.007917
97. Pavo, N., Charwat, S., Nyolczas, N., Jakab, A., Murlasits, Z., Bergler-Klein, J., et al. (2014). Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. J. Mol. Cell. Cardiol. 75, 12-24. doi: 10.1016/j.yjmcc.2014.06.016
98. Penn, M. S. (2010). SDF-1:CXCR4 axis is fundamental for tissue preservation and repair. Am. J. Pathol. 177, 2166-2168. doi: 10.2353/ajpath.2010.100803
99. Penn, M. S., Mendelsohn, F. O., Schaer, G. L., Sherman, W., Farr, M., Pastore, J., et al. (2013). An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ. Res. 112, 816-825. doi: 10.1161/CIRCRESAHA.111.300440
100. Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N., et al. (2011). Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080. doi: 10.1126/science.1200708
101. Poss, K. D., Wilson, L. G., and Keating, M. T. (2002). Heart regeneration in zebrafish. Science 298, 2188-2190. doi: 10.1126/science.1077857
102. Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., et al. (2012). In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485, 593-598. doi: 10.1038/nature11044
103. Quaini, F., Urbanek, K., Beltrami, A. P., Finato, N., Beltrami, C. A., Nadal-Ginard, B., et al. (2002). Chimerism of the transplanted heart. N. Engl. J. Med. 346, 5-15. doi: 10.1056/NEJMoa012081
104. Reber, L., Da Silva, C. A., and Frossard, N. (2006). Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur. J. Pharmacol. 533, 327-340. doi: 10.1016/j.ejphar.2005.12.067
105. Roche, E. T., Hastings, C. L., Lewin, S. A., Shvartsman, D. E., Brudno, Y., Vasilyev, N. V., et al. (2014). Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. Biomaterials 35, 6850-6858. doi: 10.1016/j.biomaterials.2014.04.114
106. Rumyantsev, P. P., and Borisov, A. (1987). DNA synthesis in myocytes from different myocardial compartments of young rats in norm, after experimental infarction and in vitro. Biomed. Biochim. Acta 46, S610-615
107. Sato, T., Amano, H., Ito, Y., Eshima, K., Minamino, T., Ae, T., et al. (2013). NSAID, aspirin delays gastric ulcer healing with reduced accumulation of CXCR4+VEGFR1+ cells to the ulcer granulation tissues. Biomed. Pharmacother. 67, 607-613. doi: 10.1016/j.biopha.2013.01.009
108. Schenk, S., Mal, N., Finan, A., Zhang, M., Kiedrowski, M., Popovic, Z., et al. (2007). Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells Dayt. Ohio 25, 245-251. doi: 10.1634/stemcells.2006-0293
109. Scimia, M. C., Gumpert, A. M., and Koch, W. J. (2013). Cardiovascular gene therapy for myocardial infarction. Expert Opin. Biol. Ther. 14, 183-195. doi: 10.1517/14712598.2014.866085
110. Semenza, G. L. (2014). Hypoxia-inducible factor 1 and cardiovascular disease. Annu. Rev. Physiol. 76, 39-56. doi: 10.1146/annurev-physiol-021113-170322
111. Senyo, S. E., Steinhauser, M. L., Pizzimenti, C. L., Yang, V. K., Cai, L., Wang, M., et al. (2013). Mammalian heart renewal by preexisting cardiomyocytes. Nature 493, 433-436. doi: 10.1038/nature11682
112. Seqqat, R., Guo, X., Rafiq, K., Kolpakov, M. A., Guo, J., Koch, W. J., et al. (2012). Beta1-adrenergic receptors promote focal adhesion signaling downregulation and myocyte apoptosis in acute volume overload. J. Mol. Cell. Cardiol. 53, 240-249. doi: 10.1016/j.yjmcc.2012.05.004
113. Shaw, S. Y., Cheng, S., Cupples, L. A., Larson, M. G., McCabe, E. L., Ngwa, J. S., et al. (2011). Genetic and clinical correlates of early-outgrowth colony-forming units. Circ. Cardiovasc. Genet. 4, 296-304. doi: 10.1161/CIRCGENETICS.110.958470
114. Shiba, Y., Fernandes, S., Zhu, W.-Z., Filice, D., Muskheli, V., Kim, J., et al. (2012). Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325. doi: 10.1038/nature11317
115. Sirish, P., López, J. E., Li, N., Wong, A., Timofeyev, V., Young, J. N., et al. (2012). MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts. J. Mol. Cell. Cardiol. 52, 264-272. doi: 10.1016/j.yjmcc.2011.10.012
116. Smart, N., Bollini, S., Dub,é, K. N., Vieira, J. M., Zhou, B., Davidson, S., et al. (2011). De novo cardiomyocytes from within the activated adult heart after injury. Nature 474, 640-644. doi: 10.1038/nature10188
117. Sopko, N. A., Turturice, B. A., Becker, M. E., Brown, C. R., Dong, F., Popoviæ, Z. B., et al. (2010). Bone marrow support of the heart in pressure overload is lost with aging. PLoS ONE 5:e15187. doi: 10.1371/journal.pone.0015187
118. Sorrentino, S. A., Doerries, C., Manes, C., Speer, T., Dessy, C., Lobysheva, I., et al. (2011). Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. J. Am. Coll. Cardiol. 57, 601-611. doi: 10.1016/j.jacc.2010.09.037
119. Sun, Y., Wang, Y., Zhang, L., Xu, C., Liu, Y., Kang, S., et al. (2014). Prevention of cardiac events caused by surgical stress in aged rats: simultaneously activating β2-adrenoceptor and inhibiting β1-adrenoceptor. Stress 17, 373-381. doi: 10.3109/10253890.2014.915392
120. Suzuki, G., Iyer, V., Cimato, T., and Canty, J. M. (2009). Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle. Circ. Res. 104, 255-264. doi: 10.1161/CIRCRESAHA.108.188730
121. Tan, C., Chen, W., Wu, Y., Lin, J., Lin, R., Tan, X., et al. (2013). Chronic aspirin via dose-dependent and selective inhibition of cardiac proteasome possibly contributed a potential risk to the ischemic heart. Exp. Gerontol. 48, 812-823. doi: 10.1016/j.exger.2013.03.012
122. Tanaka, T. D., Lancaster, J. J., Juneman, E., Bahl, J. J., and Goldman, S. (2013). Clenbuterol plus granulocyte colony-stimulating factor regulates stem/progenitor cell mobilization and exerts beneficial effect by increasing neovascularization in rats with heart failure. J. Card. Fail. 19, 503-508. doi: 10.1016/j.cardfail.2013.05.010
123. Tang, X.-L., Sanganalmath, S. K., Sato, H., Bi, Q., Hunt, G., Vincent, R. J., et al. (2011). Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction. PLoS ONE 6:e25320. doi: 10.1371/journal.pone.0025320
124. Tano, N., Narita, T., Kaneko, M., Ikebe, C., Coppen, S. R., Campbell, N. G., et al. (2014). Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study. Mol. Ther. 22, 1864-1871. doi: 10.1038/mt.2014.110
125. Thum, T., Schmitter, K., Fleissner, F., Wiebking, V., Dietrich, B., Widder, J. D., et al. (2011). Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans. Eur. Heart J. 32, 1275-1286. doi: 10.1093/eurheartj/ehq254
126. Uchida, S., De Gaspari, P., Kostin, S., Jenniches, K., Kilic, A., Izumiya, Y., et al. (2013). Sca1-derived cells are a source of myocardial renewal in the murine adult heart. Stem Cell Rep. 1, 397-410. doi: 10.1016/j.stemcr.2013.09.004
127. Urbanek, K., Quaini, F., Tasca, G., Torella, D., Castaldo, C., Nadal-Ginard, B., et al. (2003). Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 100, 10440-10445. doi: 10.1073/pnas.1832855100
128. Van Berlo, J. H., Kanisicak, O., Maillet, M., Vagnozzi, R. J., Karch, J., Lin, S.-C. J., et al. (2014). c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509, 337-341. doi: 10.1038/nature13309
129. Walsh, S., Pontén, A., Fleischmann, B. K., and Jovinge, S. (2010). Cardiomyocyte cell cycle control and growth estimation in vivo-an analysis based on cardiomyocyte nuclei. Cardiovasc. Res. 86, 365-373. doi: 10.1093/cvr/cvq005
130. Wu, J. M. F., Hsueh, Y.-C., Ch'ang, H.-J., Luo, C.-Y., Wu, L.-W., Nakauchi, H., et al. (2015). Circulating cells contribute to cardiomyocyte regeneration after injury. Circ. Res. 116, 633-641. doi: 10.1161/CIRCRESAHA.116.304564
131. Wu, L., Jia, Z., Yan, L., Wang, W., Wang, J., Zhang, Y., et al. (2013). Angiotensin II promotes cardiac differentiation of embryonic stem cells via angiotensin type 1 receptor. Differentiation 86, 23-29. doi: 10.1016/j.diff.2013.06.007
132. Xu, J., Carretero, O. A., Liao, T.-D., Peng, H., Shesely, E. G., Xu, J., et al. (2010). Local angiotensin II aggravates cardiac remodeling in hypertension. Am. J. Physiol. Heart Circ. Physiol. 299, H1328-1338. doi: 10.1152/ajpheart.00538.2010
133. Yan, L., Jia, Z., Cui, J., Yang, H., Yang, H., Zhang, Y., et al. (2011). Beta-adrenergic signals regulate cardiac differentiation of mouse embryonic stem cells via mitogen-activated protein kinase pathways. Dev. Growth Differ. 53, 772-779. doi: 10.1111/j.1440-169X.2011.01284.x
134. Yaniz-Galende, E., Chen, J., Chemaly, E., Liang, L., Hulot, J.-S., McCollum, L., et al. (2012). Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells. Circ. Res. 111, 1434-1445. doi: 10.1161/CIRCRESAHA.111.263830
135. Yoon, C.-H., Koyanagi, M., Iekushi, K., Seeger, F., Urbich, C., Zeiher, A. M., et al. (2010). Mechanism of improved cardiac function after bone marrow mononuclear cell therapy role of cardiovascular lineage commitment. Circulation 121, 2001-2011. doi: 10.1161/CIRCULATIONAHA.109.909291
136. Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., et al. (2013). Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898-907. doi: 10.1038/nbt.2682
137. Zhang, L., Guo, J., Zhang, P., Xiong, Q., Wu, S. C., Xia, L., et al. (2015). Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast. Circ. Heart Fail. 8, 156-166. doi: 10.1161/CIRCHEARTFAILURE.114.001317
138. Zhang, M., Mal, N., Kiedrowski, M., Chacko, M., Askari, A. T., Popovic, Z. B., et al. (2007). SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 21, 3197-3207. doi: 10.1096/fj.06-6558com
139. Zhang, Q., Xiang, J., Wang, X., Liu, H., Hu, B., Feng, M., et al. (2010). β2-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats. Br. J. Pharmacol. 160, 1561-1572. doi: 10.1111/j.1476-5381.2010.00813.x
140. Zhang, W. B., Du, Q. J., Li, H., Sun, A. J., Qiu, Z. H., Wu, C. N., et al. (2012). The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats. J. Cell. Mol. Med. 16, 2227-2237. doi: 10.1111/j.1582-4934.2012.01536.x